{"disease":{"id":"transplant-glomerulopathy-late-form","name":"transplant glomerulopathy late form"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT03380377","title":"Clazakizumab for Chronic and Active Antibody Mediated Rejection Post-Kidney Transplant","phase":"PHASE1, PHASE2","overall_status":"COMPLETED","enrollment_count":10,"lead_sponsor_name":"Stanley Jordan, MD","has_results":true}],"total":1},"guidelines":[],"source":"Drug Landscape verified database"}